← Leaderboards
Christopher Lowther Skelly
University Of Chicago
$621,000
Attributed
$621,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $124.2K · FY2008–12$200K$150K$100K$50K$0
'08
'09
'10
'11
'12
Funding mix
By agency
NIH$621,000 · 1
By mechanism
K08$621,000 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Chicago
Same institution · by research overlap
- Maryellen L. Giger$19,209,750
- Anthony W Maresso$18,790,258
- Gayle E Woloschak$21,789,151
- Shabaana A. Khader$24,868,402
- Michelle M Le Beau$39,023,275
Others in their field
Top investigators on “Affect”
- Gerald T Nepom · Benaroya Research Inst At Virginia Mason$298,740,071
- Judith S. Currier · University Of California Los Angeles$287,585,588
- Chanza Baytop · Westat, Inc.$271,217,917
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$209,385,844
- David Heimbrook · Leidos Biomedical Research, Inc.$168,138,264
- Daniel R Kuritzkes · Brigham And Women'S Hospital$151,687,019
Research focus
AffectAngioplastyAntiviral AgentsApoptosisAttenuatedBiochemicalBiochemistryBiological ModelsBiologyBlood VesselsBypassCardiovascular SystemCareerCellsCell TypeCellular BiologyCellular OncologyChairpersonChicagoCytolysisDesignDoctor Of MedicineDoseAcyclovir
Grant awards (5)
Herpes Simplex Virus Therapy for the Treatment of Neointimal Hyperplasia$124,200
K08 · FY2012 · HL · contact PI
Herpes Simplex Virus Therapy for the Treatment of Neointimal Hyperplasia$124,200
K08 · FY2011 · HL · contact PI
Herpes Simplex Virus Therapy for the Treatment of Neointimal Hyperplasia$124,200
K08 · FY2010 · HL · contact PI
Herpes Simplex Virus Therapy for the Treatment of Neointimal Hyperplasia$124,200
K08 · FY2009 · HL · contact PI
Herpes Simplex Virus Therapy for the Treatment of Neointimal Hyperplasia$124,200
K08 · FY2008 · HL · contact PI